Dr. Richard T. Frederick, M.D.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- New York Medical College (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 461
Licensed in California since 2000, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: New York Medical College
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
CA license A71441 (first issued 2000; current) -
Hepatology Physician
CA license A71441 (first issued 2000; current) -
Internal Medicine Physician
CA license A71441 (first issued 2000; current) -
Transplant Hepatology Physician
CA license A71441 (first issued 2000; current) -
Transplant Surgery Physician
CA license A71441 (first issued 2000; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sutter Medical Center, Sacramento Sacramento, CA
- California PAcific Medical Center- Van Ness Campus San Francisco, CA
- California PAcific Medical Ctr-Davies Campus Hosp San Francisco, CA
- Oroville Hospital Oroville, CA
- Enloe Health Chico, CA
Medical groups
- Sutter Bay Medical Foundation (3,829 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 461
- Services billed
- 1,066
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 379 | 267 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 238 | 63 |
| Established patient office or other outpatient visit, 30-39 minutes | 103 | 92 |
| Critical care, first 30-74 minutes | 56 | 13 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 43 | 39 |
| New patient office or other outpatient visit, 60-74 minutes | 37 | 37 |
| Measurement of liver stiffness | 26 | 26 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 23 | 14 |
| New patient office or other outpatient visit, 45-59 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tacrolimus Other prescribers in San Francisco, CA | 248 |
| Ursodiol Other prescribers in San Francisco, CA | 241 |
| Vemlidy (tenofovir alafenamide) | 151 |
| Xifaxan (rifaximin) Other prescribers in San Francisco, CA | 122 |
| Entecavir | 120 |
| Lactulose Other prescribers in San Francisco, CA | 72 |
| Furosemide Other prescribers in San Francisco, CA | 69 |
| Pantoprazole Sodium Other prescribers in San Francisco, CA | 65 |
| Prednisone Other prescribers in San Francisco, CA | 65 |
| Mycophenolate Mofetil Other prescribers in San Francisco, CA | 62 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 35 payments worth $45,689 in total to this clinician.
| Madrigal Pharmaceuticals | $41,813 |
|---|---|
| Mallinckrodt Hospital Products Inc. | $2,995 |
| Cipla USA Inc. | $450 |
| Gilead Sciences, Inc. | $140 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119 |
| Cook Medical LLC | $112 |
| Ipsen Biopharmaceuticals, Inc | $61.54 |
| Compensation for services other than consulting (speaking, faculty) | $39,307 |
|---|---|
| Consulting Fee | $3,240 |
| Travel and Lodging | $1,621 |
| Food and Beverage | $1,522 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Madrigal Pharmaceuticals Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Madrigal Pharmaceuticals Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Madrigal Pharmaceuticals Aug 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Madrigal Pharmaceuticals Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Jul 30, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Mallinckrodt Hospital Products Inc. Oct 29, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $2,790 |
All 20 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Madrigal Pharmaceuticals Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Mallinckrodt Hospital Products Inc. Oct 29, 2025 | Consulting Fee TERLIVAZ · CRITICAL CARE | $2,790 |
| Madrigal Pharmaceuticals Oct 29, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to BURLINGAME, CA | $141 |
| Madrigal Pharmaceuticals Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Sep 11, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to BERKELEY, CA | $131 |
| Madrigal Pharmaceuticals Aug 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Madrigal Pharmaceuticals Aug 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to CHICO, CA | $16.93 |
| Madrigal Pharmaceuticals Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Aug 12, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to OAKLAND, CA | $122 |
| Madrigal Pharmaceuticals Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $1,234 |
| Madrigal Pharmaceuticals Jul 30, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Jul 30, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to LAFAYETTE, CA | $185 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to BURLINGAME, CA | $116 |
| Madrigal Pharmaceuticals Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Madrigal Pharmaceuticals Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,878 |
| Madrigal Pharmaceuticals Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,935 |
| Madrigal Pharmaceuticals Feb 11, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to REDDING, CA · in-kind | $810 |
| Cipla USA Inc. Feb 10, 2025 | Consulting Fee | $450 |
| Madrigal Pharmaceuticals Jan 29, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to MIAMI, FL | $98.82 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $106,885 in research payments for these studies, mostly to the institutions running them.
- A Two Part Phase IIa b Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose-ranging Study to Assess Efficacy, Safety, and Tolerability of the Combination of Zibotentan and Dapagliflozin, and …
AstraZeneca Pharmaceuticals LP - A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
Bausch Health US, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.